Debra A. Odink
President chez Thryv Therapeutics, Inc.
Profil
Debra A.
Odink is currently the President & Chief Development Officer at Thryv Therapeutics, Inc. She previously worked as the Associate Director-Technical Affairs at Elan Pharmaceuticals, LLC.
She also held the position of VP-Pharmaceutical Chemistry & Product Development at Peninsula Pharmaceuticals, Inc. from 2002 to 2005.
From 2005 to 2016, she served as the Chief Technology Officer & Senior Vice President at Anthera Pharmaceuticals, Inc. Dr. Odink was also a Principal at Hoffmann-La Roche, Inc. and the Chief Development Officer at SiteOne Therapeutics, Inc. Additionally, she worked as the Senior Vice President-Technical Operations at Eiger BioPharmaceuticals, Inc. Dr. Odink obtained her undergraduate degree from California State University-Stanislaus and her doctorate degree from the University of California, Davis.
Postes actifs de Debra A. Odink
| Sociétés | Poste | Début |
|---|---|---|
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | President | 01/09/2022 |
Anciens postes connus de Debra A. Odink
| Sociétés | Poste | Fin |
|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 05/01/2016 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Corporate Officer/Principal | 01/07/2005 |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Corporate Officer/Principal | - |
| EIGER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Formation de Debra A. Odink
| California State University-Stanislaus | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | Health Services |
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |